Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for reducing lipoprotein(a) levels by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)

Methods for reducing lipoprotein(a) levels by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)

US Patent 11116839 · Granted Sep 14, 2021

Estimated economic value: $141,411,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for reducing remnant cholesterol and other lipoprotein fractions by admi2018
Methods for reducing lipoprotein(a) levels by administering an inhibitor of prop2018
Methods for treating hypercholesterolemia and reducing LDL-C using antibodies to2017
Methods for treating hypercholesterolemia using antibodies to PCSK92013
Support apparatus for hammocks1990